Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Scott E Mambourg"'
Publikováno v:
Annals of Pharmacotherapy. 43:862-867
Background Varenicline is a selective nicotinic receptor partial agonist used to aid in the process of smoking cessation. Research on varenicline's approval for marketing demonstrated that after 12 weeks of treatment, at least 44% of patients success
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bad515853a5c6646213d6bc2d106096e
https://doi.org/10.1345/aph.1l661
https://doi.org/10.1345/aph.1l661
Autor:
Arthur L.M. Swislocki, Joanne LaFleur, Jannet M. Carmichael, Chandra L. Steenhoek, Julie Horne, Scott E Mambourg, Joy Meier, Jonathan R. Nebeker
Publikováno v:
The Annals of pharmacotherapy. 49(5)
Background: Fracture absolute risk assessment (FARA) is recommended for guiding osteoporosis treatment decisions in males. The best strategy for applying FARA in the clinic setting is not known. Objectives: We compared 2 FARA tools for use with elect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25e78fb9207c16b85d22b661c58b7af2
https://pubmed.ncbi.nlm.nih.gov/25712443
https://pubmed.ncbi.nlm.nih.gov/25712443
Publikováno v:
Expert opinion on drug safety. 9(3)
Patients with a psychiatric diagnosis have a higher prevalence of smoking compared to the general population. Varenicline is a first-line pharmacotherapy option to assist in smoking cessation. Clinical trials during drug development excluded patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a617a14b7dae1cb1fa489b51f094f80
https://pubmed.ncbi.nlm.nih.gov/20166836
https://pubmed.ncbi.nlm.nih.gov/20166836